Publication: Antinociceptive effect of amikacin and its interaction with morphine and naloxone
| dc.contributor.authors | Atamer-Simsek, S; Olmez-Salvarli, H; Guc, O; Eroglu, L | |
| dc.date.accessioned | 2022-03-12T17:01:39Z | |
| dc.date.accessioned | 2026-01-11T17:45:21Z | |
| dc.date.available | 2022-03-12T17:01:39Z | |
| dc.date.issued | 2000 | |
| dc.description.abstract | Amikacin sulphate (30 mg kg(-1)) administered:either intraperitoneally (i.p.) or subcutaneously (s.c.) produced antinociceptive effect in BALB/c mice in the acetic acid writhing test which is employed as an inflammatory pain model. The lack of difference between two routes with ri:gard to antinociceptive potency was taken as evidence for the absence of a local effect. Amikacin sulphate-induced antinociception seems unlikely to be due to non-specific behaviour alteration, since this drug, at a dose range of 15-100 mg kg(-1) did not affect motor coordination of mice in rot-a-rod test. Morphine (1 mg kg(-1)) also caused antinociception when administered i.p. or s.c. but the effect was greater with the latter route. At the i.p. site; the concurrent use of amikacin and morphine produced more remarkable antinociception compared to their individual usages. Besides, naloxone (2 mg kg(-1)) significantly decreased antinociceptive effect of amikacin but itself also exerted antinociception. At present, we have no plausible explanation for these findings at the i.p. site. (C) 2000 Academic Press. | |
| dc.identifier.doi | 10.1006/phrs.1999.0599 | |
| dc.identifier.issn | 1043-6618 | |
| dc.identifier.pubmed | 10675289 | |
| dc.identifier.uri | https://hdl.handle.net/11424/227399 | |
| dc.identifier.wos | WOS:000085513500013 | |
| dc.language.iso | eng | |
| dc.publisher | ACADEMIC PRESS LTD | |
| dc.relation.ispartof | PHARMACOLOGICAL RESEARCH | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | amikacin sulphate | |
| dc.subject | opioids | |
| dc.subject | writhing test | |
| dc.subject | BALB/c mice | |
| dc.subject | ADMINISTERED AMINOGLYCOSIDE ANTIBIOTICS | |
| dc.subject | CALCIUM-CHANNEL BLOCKERS | |
| dc.subject | DIFFERENTIAL SENSITIVITY | |
| dc.subject | DIVALENT-CATIONS | |
| dc.subject | OPIOID AGONISTS | |
| dc.subject | FORMALIN TEST | |
| dc.subject | N-TYPE | |
| dc.subject | MICE | |
| dc.subject | ANALGESIA | |
| dc.subject | PAIN | |
| dc.title | Antinociceptive effect of amikacin and its interaction with morphine and naloxone | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 360 | |
| oaire.citation.issue | 3 | |
| oaire.citation.startPage | 355 | |
| oaire.citation.title | PHARMACOLOGICAL RESEARCH | |
| oaire.citation.volume | 41 |
